Pityriasis versicolor: quality of studies

References

• Gupta AK, Ryder J, Bluhm R et al, Onychomycosis: quality of studies. J Cutan Med 2003 (in press).
   Google Scholar
• Budimulja U, Paul C, One-week terbinafine 1% solution in pityriasis versicolor: twice-daily application is more effec- tive than once daily. J Dermatol Treat (2002) 13: 39–40.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Gupta AK, Al Mofadi A et al, Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol (2002) 138: 69–73.
   PubMed Web of Science ®Google Scholar
• Farshchian M, Yaghoobi R, Samadi K, Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat (2002) 13: 73–6.
   PubMedGoogle Scholar
• Ko¨se O, Tastan HB, Gu¨ r AR, Kurumlu Z, Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J Dermatol Treat (2002) 13: 77–9.
   PubMed Web of Science ®Google Scholar
• Bhogal CS, Singal A, Baruah MC, Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J Dermatol (2001) 28: 535–9.
   PubMed Web of Science ®Google Scholar
• Savin R, Eisen D, Fradin MS, Lebwohl M, Tinea versicolor treated with terbinafine 1% solution. Int J Dermatol (1999) 38: 863–5.
   PubMedGoogle Scholar
• Segal R, Kricheli D, Zukrov B, David M, Treatment of pityriasis versicolor with bifonazole shampoo: a rando- mized double-blind study. J Dermatol Treat (1999) 10: 185–8.
   Web of Science ®Google Scholar
• Shemer A, Nathansohn N, Kaplan B, Trau H, Itraconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat (1999) 10: 19–23.
   Web of Science ®Google Scholar
• Lange DS, Richards HM, Guarnieri J et al, Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo- controlled trial. J Am Acad Dermatol (1998) 39: 944–50.
   PubMed Web of Science ®Google Scholar
• Silva H, Gibbs D, Arguedas J, A comparison of fluconazole with ketoconazole, itraconazole, and clo- trimazole in the treatment of patients with pityriasis versicolor. Curr Ther Res (1998) 59: 203–14.
   Google Scholar
• Amer MA, Abdallah MA, Abdel-Aal MA et al, Fluconazole in the treatment of tinea versicolor. Int J Dermatol (1997) 36: 940–2.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Hersle K, Nordin P, Pityriasis versicolor: clinical experience with Lamisil1 cream and Lamisil1 dermgel. Dermatology (1997) 194: 19–21.
   PubMedGoogle Scholar
• Fernandez-Nava HD, Laya-Cuadra B, Tianco EAV, Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor. Int J Dermatol (1997) 36: 64–6.
   PubMedGoogle Scholar
• Vermeer BJ, Staats CCG, The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study. Derma- tology (1997) 194: 22–4.
   Google Scholar
• Hickman JG, A double-blind, randomized, placebo- controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J Am Acad Dermatol (1996) 34: 785–7.
   PubMed Web of Science ®Google Scholar
• Katsambas A, Rigopoulos D, Antoniou C et al, Econazole 1% shampoo versus selenium in the treatment of tinea versicolor: a single-bind randomized clinical study. Int J Dermatol (1996) 35: 667–8.
   PubMedGoogle Scholar
• Ko¨se O, Fluconazole versus itraconazole in the treat- ment of tinea versicolor. Int J Dermatol (1995) 34: 498–9.
   PubMedGoogle Scholar
• Galimberti RL, Bonino M, Flores V et al, Ultra-short topical treatment of pityriasis versicolor with 2.5% bifonazole cream. Clin Exp Dermatol (1993) 18: 25–9.
   PubMedGoogle Scholar
• Nasarre J, Umbert P, Herrero E et al, Therapeutic efficacy and safety of the new antimycotic serta- conazole in the treatment of pityriasis vesicolor. Arzneimittelforschung (1992) 42: 764–7.
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Katsambas A, Antoniou C et al, Tinea versicolor treated with fluconazole shampoo. Int J Dermatol (1992) 31: 664–5.
   PubMedGoogle Scholar
• Aste N, Pau M, Pinna AL et al, Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses (1991) 34: 353–7.
   PubMedGoogle Scholar
• Montes LF, Oakes RA, Pert P et al, Topical griseofulvin in tinea versicolor: a double-blind study. J Am Acad Dermatol (1991) 25: 726–8.
   PubMedGoogle Scholar
• Cuce` LC, Belda W, Ribeiro EBD, Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment. Rev Inst Med Trop Sao Paulo (1990) 32: 181–4.
   PubMedGoogle Scholar
• Hernandez-Perez E, A comparison between two differ- ent regimens of monthly application with bifonazole spray 1% in pityriasis versicolor. Int J Dermatol (1990) 29: 438–40.
   PubMedGoogle Scholar
• Roseeuw D, Willemsen M, Kint R et al, Itraconazole in the treatment of superficial mycoses – a double-blind study vs placebo. Clin Exp Dermatol (1990) 15: 101–4.
   PubMed Web of Science ®Google Scholar
• Zaias N, Pityriasis versicolor with ketoconazole. J Am Acad Dermatol (1989) 20: 703–4.
   PubMedGoogle Scholar
• Aste N, Pau M, Cordaro CI, Biggio P, Double-blind study with fenticonazole or bifonazole lotions in pityriasis versicolor. Int J Clin Pharmacol Res (1988) 8: 271–3.
   PubMedGoogle Scholar
• Alchorne MMA, Paschoalick RC, Forjaz MHH, Com- parative study of tioconazole and clotrimazole in the treatment of tinea versicolor. Clin Ther (1987) 9: 360–7.
   PubMedGoogle Scholar
• Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Belaustegui ARN, Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev Infect Dis (1987) 9: S121–7.
   Google Scholar
• Del Palacio Hernanz A, Lopez Gomez S, Iglesias Diez L, Short course bifonazole therapy in pityriasis versicolor. Clin Exp Dermatol (1987) 12: 270–2.
   PubMedGoogle Scholar
• Estrada RA, Itraconazole in pityriasis versicolor. Rev Infect Dis (1987) 9: S128–30.
   PubMedGoogle Scholar
• Faergemann J, Treatment of pityriasis versicolor with itraconazole. Mykosen (1987) 30: 44–7.
   PubMedGoogle Scholar
• Galimberti RL, Villalba I, Galarza S et al, Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment. Rev Infect Dis (1987) 9: S134–8.
   Google Scholar
• Morales-Doria M, Pityriasis versicolor: efficacy of two five-day regimens of itraconazole. Rev Infect Dis (1987) 9: S131–3.
   Google Scholar
• Athow-Frost TAM, Freeman K, Mann TAN et al, Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream. Curr Med Res Opin (1986) 10: 107–16.
   PubMedGoogle Scholar
• Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O et al, Itraconazole therapy in pityriasis versicolor. Br J Dermatol (1986) 115: 217–25.
   PubMedGoogle Scholar
• Hernandez-Perez E, A comparison between one and two weeks’ treatment with bifonazole in pityriasis versicolor. J Am Acad Dermatol (1986) 14: 561–4.
   PubMedGoogle Scholar
• Savin RC, Horwitz SN, Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol (1986) 15: 500–3.
   PubMed Web of Science ®Google Scholar
• Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. Clin Ther (1985) `7: 574–83.
   Google Scholar
• Chu AC, Comparative clinical trial of bifonazole solution versus selenium sulphide shampoo in the treatment of pityriasis versicolor. Dermatologica (1984) 169: 81–6.
   PubMedGoogle Scholar
• Hay RJ, Midgeley G, Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol (1984) 9: 571–3.
   PubMedGoogle Scholar
• Mora RG, Greer DL, Comparative efficacy and tolerance of 1% bifonazole cream and bifonazole cream vehicle in patients with tinea versicolor. Dermatologica (1984) 169: 87–92.
   PubMedGoogle Scholar
• Sanchez JL, Torres VM, Double-blind efficacy study of selenium sulfide in tinea versicolor. J Am Acad Dermatol (1984) 11: 235–41.
   PubMed Web of Science ®Google Scholar
• Savin RC, Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. J Am Acad Dermatol (1984) 10: 824–30.
   PubMed Web of Science ®Google Scholar
• Tanenbaum L, Anderson C, Rosenberg MJ, Akers W, 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor: a double-blind, multicenter study. Arch Dermatol (1984) 120: 216– 19.
   PubMedGoogle Scholar
• Vicik GJ, Mendiones M, Quinones CA, Thorne EG, A new treatment for tinea versicolor using econazole nitrate 1.0 percent cream once a day. Cutis (1984) 33: 570–1.
   PubMedGoogle Scholar
• Bamford JTM, Treatment of tinea versicolor with sulfur-salicylic shampoo. J Am Acad Dermatol (1983) 8: 211–13.
   PubMedGoogle Scholar
• Fredriksson T, Faergemann J, Double-blind comparison of a zinc pyrithione shampoo and its shampoo base in the treatment of tinea versicolor. Cutis (1983) 31: 436–7.
   PubMedGoogle Scholar
• Fredriksson T, Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica (1983) 166: 14–19.
   PubMedGoogle Scholar
• Faergemann J, Dja¨ rv L, Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis (1982) 30: 542–50.
   PubMed Web of Science ®Google Scholar
• Urcuyo FG, Zaias N, The successful treatment of pityriasis versicolor by systemic ketoconazole. J Am Acad Dermatol (1982) 6: 24–5.
   PubMed Web of Science ®Google Scholar
• Cuce` LC, Assunc¸a˜o BFC, Medawar LGA et al, Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis. J Int Med Res (1980) 8: 144–7.
   PubMedGoogle Scholar
• Intini C, Battaglia A, Mangiarotti AM et al, Multicentre clinical study with tolciclate in the local treatment of skin mycoses in 1083 patients. Pharmatherapeutica (1980) 2: 439–49.
   Google Scholar
• Quin˜ones CA, Tinea versicolor: new topical treatments. Cutis (1980) 25: 386–8.
   PubMedGoogle Scholar
• Clayton R, du Vivier A, Savage M, Double-blind trial of 1% clotrimazole cream and whitfield ointment in the treatment of pityriasis versicolor. Arch Dermatol (1977) 113: 849–50.
   PubMedGoogle Scholar
• Zaias N, Battistini F, Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution. Arch Dermatol (1977) 113: 307–8.
   PubMedGoogle Scholar
• Spiekermann PH, Young MD, Clinical evaluation of clotrimazole: a broad-spectrum antifungal agent. Arch Dermatol (1976) 112: 350–2.
   PubMedGoogle Scholar
• Clayton YM, Connor BL, Clinical trial of clotrimazole in the treatment of superficial fungal infections. Postgrad Med J (1974) 50: 66–8.
   PubMedGoogle Scholar
• Comaish JS, Double-blind comparison of clotrimazole with Whitfield’s and Nystatin ointments. Postgrad Med J (1974) 50: 73–5.
   PubMedGoogle Scholar
• Clayton YM, Connor BL, Comparison of clotrimazole cream, Whitfield’s ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. Br J Dermatol (1973) 89: 297–303.
   PubMed Web of Science ®Google Scholar
• Svejgaard E, Double-blind trial of miconazole in dermatomycosis. Acta Derm Venereol (1973) 53: 497–500.
   PubMed Web of Science ®Google Scholar
• Hersle K, Selenium sulphide treatment of tinea versicolor. Acta Derm Venereol (1971) 51: 476–8.
   PubMedGoogle Scholar
• Amichai B, Treatment of pityriasis versicolor with a shampoo containing 1% bifonazole (Agispor1 shampoo) in children. Clin Exp Dermatol (2000) 25: 660.
   PubMedGoogle Scholar
• Shahid J, Ihsan Z, Khan S, Oral fluconazole in the treatment of pityriasis versicolor. J Dermatol Treat (2000) 11: 101–3.
   Web of Science ®Google Scholar
• Montero-Gei F, Robles ME, Suchil P, Fluconazole vs itraconazole in the treatment of tinea versicolor. Int J Dermatol (1999) 38: 601–3.
   PubMed Web of Science ®Google Scholar
• Georgiou S, Monastirli A, Pasmatzi E et al, Oral itraconazole therapy for pityriasis versicolor. J Eur Acad Dermatol Venereol (1997) 8: 203–7.
   Google Scholar
• Sadeque JBMZ, Shahidullah M, Shah OR, Kamal M, Systemic ketoconazole in the treatment of tinea versicolor. Int J Dermatol (1995) 34: 504–5.
   PubMedGoogle Scholar
• Faergemann J, Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (1992) 72: 74–5.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study. Mycoses (1988) 31: 377–9.
   PubMedGoogle Scholar
• Alteras I, Sandbank M, Segal R, Two years of follow-up of oral ketoconazole therapy in 60 cases of pityriasis versicolor. Dermatologica (1987) 175: 142–4.
   PubMedGoogle Scholar
• Cauwenbergh G, De Doncker P, Stoops K et al, Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev Infect Dis (1987) 9: S146–52.
   Google Scholar
• Del Palacio Hernanz A, Lopez Gomez S, Iglesias Diez L, A clinical and mycological assessment of tioconazole solution in the treatment of superficial dermatomy- coses. Clin Ther (1987) 9: 333–8.
   PubMedGoogle Scholar
• Hay RJ, Adriaans B, Midgley G et al, A single application of bifonazole 1% lotion in pityriasis versicolor. Clin Exp Dermatol (1987) 12: 315.
   PubMedGoogle Scholar
• Panconesi E, Difonzo E, Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Rev Infect Dis (1987) 9: S109–13.
   Google Scholar
• Robertson LI, Itraconazole in the treatment of wide- spread tinea versicolor. Clin Exp Dermatol (1987) 12: 178–80.
   PubMedGoogle Scholar
• Sau´l A, Bonifa´ z A, Arias I, Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Rev Infect Dis (1987) 9: S100–3.
   Google Scholar
• Soyinka F, Bifonazole in the treatment of fungal skin infections in the tropics: a clinical and mycological study. Curr Med Res Opin (1987) 10: 390–6.
   PubMed Web of Science ®Google Scholar
• Delescluse J, Cauwenbergh G, Degreef H, Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor. Br J Dermatol (1986) 114: 701–3.
   PubMedGoogle Scholar
• Galimberti R, Belli L, Gatti JC et al, An open, multicentre assessment of the effectiveness of bifonazole in the treatment of tinea (pityriasis) versicolor. Pharmatherapeutica (1985) 4: 109–12.
   PubMedGoogle Scholar
• Hira SK, Din SN, Patel JS, Econazole 1% in the treatment of pityriasis versicolor in Zambia. J Am Acad Dermatol (1985) 12: 580–1.
   PubMedGoogle Scholar
• Brown C, Caro I, Condry P et al, Multicenter clinical evaluation of ketoconazole in the treatment of cutaneous fungal infections. Cutis (1984) 33: 578–81.
   PubMed Web of Science ®Google Scholar
• Conti-Diaz IA, Civila E, Asconegui F, Treatment of superficial and deep-seated mycoses with oral ketoco- nazole. Int J Dermatol (1984) 23: 207–10.
   PubMedGoogle Scholar
• Manna VK, Pearse AD, Marks R, The effect of povidone-iodine paint on fungal infection. J Int Med Res (1984) 12: 121–3.
   PubMedGoogle Scholar
• Rausch LJ, Jacobs PH, Tinea versicolor: treatment and prophylaxis with monthly administration of ketocona- zole. Cutis (1984) 34: 470–1.
   PubMed Web of Science ®Google Scholar
• Schewach-Millet M, Kahana M, Levy A et al, Ketoconazole – an effective treatment for disseminated pityriasis versicolor. Isr J Med Sci (1984) 20: 417–19.
   PubMedGoogle Scholar
• Prestia AE, Topical benzoyl peroxide for the treatment of tinea versicolor. J Am Acad Dermatol (1983) 9: 277–8.
   PubMedGoogle Scholar
• Jolliffe DS, Ngai YL, Systemic treatment of tinea versicolor with ketoconazole in forty-four patients. Clin Exp Dermatol (1981) 6: 625–8.
   PubMedGoogle Scholar
• Borelli D, Treatment of pityriasis versicolor with ketoconazole. Rev Infect Dis (1980) 2: 592–5.
   PubMedGoogle Scholar
• Faergemann J, Fredriksson T, An open trial of the effect of a zinc pyrithione shampoo in tinea versicolor. Cutis (1980) 25: 667–9.
   PubMedGoogle Scholar
• Welsh O, Rodriguez M, Treatment of dermatomycoses with ketoconazole. Rev Infect Dis (1980) 2: 582–5.
   PubMedGoogle Scholar
• Faergemann J, Fredriksson T, Propylene glycol in the treatment of tinea versicolor. Acta Derm Venereol (1979) 60: 92–3.
   Google Scholar
• Gip L, The topical therapy of pityriasis versicolor with clotrimazole. Postgrad Med J (1974) 50: 59–60.
   PubMedGoogle Scholar
• Mills OH, Kligman AM, Tretinoin in tinea versicolor. Arch Dermatol (1974) 110: 638(letter).
   Google Scholar
• Polemann G, Clinical experience in the local treatment of dermatomycoses with clotrimazole. Postgrad Med (1974) 50: 54–6.
   Google Scholar
• Difonzo EM, Cilli P, Panconesi E, Itraconazole in the prophylactic treatment of recurrent pityriasis versico- lor: results of a multicentric Italian study. Semin Dermatol (Italian Edition) (1993) 61: 3–16.
   Google Scholar
• Fioroni A, Cilli P, Altomare G, Finzi AF, Itraconazole: a new oral antimycotic for the treatment of pityriasis versicolor. Comparative clinical study of two treatment regimens. Micologia Dermatologica (1992) 6: 43–6.
   Google Scholar
• Chang SH, Suh DH, Kim SH, Youn JI, A clinical study of oral itraconazole therapy in tinea versicolor. J Korean Med Assoc (1991) 34: 197–202.
   Google Scholar
• Massone L, Pestarino A, Borghi S et al, Oral itraconazole in the treatment of pityriasis versicolor: a comparison of two different dosage regimens. Micologia Dermatologica (1991) 5: 90–2.
   Google Scholar
• Simoni S, Cilli P, Itraconazole in the treatment of pityriasis versicolor: results obtained in 30 patients. G Ital Dermatol Venereol (1991) 126: 41–3.
   Google Scholar
• Giam YC, Tham SN, Ketoconazole in tinea versicolor: is ten day therapy adequate? Singapore Med J (1987) 28: 13–17.
   PubMedGoogle Scholar
• Giam YC, Rajan VS, Oral ketoconazole – a new treatment for tinea versicolor. Singapore Med J (1984) 25: 157–60.
   PubMedGoogle Scholar
• Haroon RS, Tareen MI, Hafiz A, An open study of tioconazole 1% dermal cream in patients with pityriasis versicolor. J Pak Med Assoc (1984) 34: 361–2.
   PubMedGoogle Scholar
• Bigby M, Gadenne AS, Understanding and evaluating clinical trials. J Am Acad Dermatol (1996) 34: 555–90.
   PubMedGoogle Scholar